ARCHIVES

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

This article is from The Cancer Letter archive.

Vol. 34 No. 04 | February 1, 2008

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Donald Coffey Is President-Elect Of NCCR; Coalition Elects Five New Board.

January 28, 2000